Authors: Bopp, MKF Morell, A Indrak, K Parkkinen, J Mertens, H Mohr, H Colamartino, P Stanescu, I Oyonarte, S Delaney, FM Padilla, A

Citation: Mkf. Bopp et al., Pathogen inactivation of labile blood products, TRANSFUS M, 11(3), 2001, pp. 149-175

Authors: Tiercy, JM Bujan-Lose, M Chapuis, B Gratwohl, A Gmur, J Seger, R Kern, M Morell, A Roosnek, E

Citation: Jm. Tiercy et al., Bone marrow transplantation with unrelated donors: what is the probabilityof identifying an HLA-A/B/Cw/DRB1/B3/B5/DQB1-matched donor?, BONE MAR TR, 26(4), 2000, pp. 437-441

Authors: Morell, A

Citation: A. Morell, Alfred Hassig - 1921-1999 - Obituary, VOX SANGUIN, 78(2), 2000, pp. 69-71

Authors: Nydegger, UE Mohacsi, PJ Escher, R Morell, A

Citation: Ue. Nydegger et al., Clinical use of intravenous immunoglobulins, VOX SANGUIN, 78, 2000, pp. 191-195

Authors: Morell, A Kern, M Salvisberg, G Wenger, I

Citation: A. Morell et al., Swiss Bone Marrow Donor Registry, INFUSIONSTH, 26, 1999, pp. 6-9